Dr. Sulak on a neglected treatment option for opioid addiction: medical cannabis.
Addiction & Alcoholism
In this edition of Cannabis Conversations, Project CBD Director, Martin A. Lee, discusses the benefits of CBD, the “entourage effect” and the microbiome with Dr. Ethan Russo.
Marijuana smokers have been stereotypically mocked for short-term memory loss, and there is genuine concern about memory impairment due to cannabis consumption, particularly among seniors who are considering cannabis as a therapeutic option.
But the importance of forgetting in mental health should not be underestimated.
Quality sleep is critical to human emotional, mental and physical health, yet it eludes between 50-70 million Americans. In this report, we will explore why sleep matters, the role of the endocannabinoid system in sleep, and how cannabis and its components — in particular, CBD and THC — may benefit those with sleep issues.
Pamela is newly pregnant with her third child. She and her husband think this is going to be their last one because she is having a dreadful time with nausea – morning sickness that lasts all day long. She knows all the tricks. Saltines by her bedside, taking Vitamin B6 and B12, and eating frequently even though her stomach is queasy. She tried ginger. She tried acupuncture. She considered hypnosis. None of it is working, and the added stress of two little ones who still need her attention is making her pregnancy a miserable experience.
I wanted to relay the experience I’m having with CBD aiding opiate withdrawal. I am a 72-year-old woman. A doctor put me on fentanyl patches about 10 years ago, after trying various painkillers for my intense fibromyalgia pain. They did not notify me how difficult, if not impossible, it would be to get off of them. I use the generic Mylan brand, which can be cut down without deleterious effects. Several times over the years I have attempted to taper down, but even cutting off the tiniest sliver of the patch resulted in intense withdrawal symptoms, so I gave up.
During the last week of June, more than 400 scientists from 25 countries met in Montreal for the 27th annual symposium of the International Cannabinoid Research Society (ICRS). Several presentations and posters showcased new findings about cannabidiol (CBD), the non-euphoric component of the cannabis plant that is transforming the medical marijuana landscape.
The Society of Cannabis Clinicians calls on the medical board for more sensible policies towards cannabis, which includes collaboration with medical cannabis dispensaries as well as removing the stigma of cannabis as a substance of abuse.
A patient survey collaboration between Care by Design and Project CBD demonstrated that cannabis appears to be an effective pain management tool with few negative side effects. The study also found that a significant decrease in opiate usage among elderly patients while taking medical cannabis.
Misinformation can masquerade as science, especially when it comes to cannabis. Adrian Devitt-Lee highlights how analysis can be skewed for a variety of factors and gives insight on how to spot faulty research data.